Systemic
发表于 2025-3-30 11:44:48
http://reply.papertrans.cn/71/7014/701387/701387_51.png
ACME
发表于 2025-3-30 13:00:31
Lung Cancer,n tumor type, demonstrating molecular connections between diverse tumors. Immunotherapy in lung cancer has also redefined treatment paradigms for patients with lung cancer. Initially, single-agent treatment with programmed death 1 (PD-1) and programmed death receptor ligand 1 (PD-L1) antibodies demo
偏见
发表于 2025-3-30 20:05:35
Multiple Myeloma,er tandem transplantations are of significant benefit. Moreover, allogeneic transplantations yield relatively high transplant-related mortality rates and uncertain benefit over ASCT and therefore is not widely performed. In relapsed disease, disease-related, patient-related, and treatment-related pa
FUSE
发表于 2025-3-30 22:48:49
Colon Cancer,ducing new agents despite several well-done trials conducted in the United States and Europe. We have to revisit as a scientific community the use of the metastatic setting as a predictive environment for the adjuvant setting. We have, however, been able to reduce the intensity of existing therapies
Euthyroid
发表于 2025-3-31 04:08:18
Genomic Cancer Risk Assessment,gnition of potential germline genomic information in the context of tumor analyses for precision medicine. The scope of knowledge, tools, and expertise required for practitioner-level competence in genomic counseling is summarized and highlights the need for genetics and genomics professional educat
极深
发表于 2025-3-31 06:37:26
Triple-Negative Breast Cancer,ents still face increased risk of early metastasis and death from TNBC (Anders and Carey. Clin Breast Cancer 9:S73–S81, 2009). In the metastatic setting following first-line treatment, median overall survival is 6–13 months, and medial progression-free survival (PFS) is 3–4 months (Kassam et al. Cli
ironic
发表于 2025-3-31 11:02:40
Digital Patient Engagement and Social Media,, research reports, state of the science papers, position papers, and clinical guidelines from professional organizations, the primary purpose of this chapter is to describe the current use of digital patient engagement and social media use in oncology care, and to describe evidence-based informatio
扩大
发表于 2025-3-31 17:12:59
http://reply.papertrans.cn/71/7014/701387/701387_58.png
内部
发表于 2025-3-31 17:49:28
http://reply.papertrans.cn/71/7014/701387/701387_59.png
寡头政治
发表于 2025-3-31 22:16:43
http://reply.papertrans.cn/71/7014/701387/701387_60.png